Patients predominantly in the early stages of HF, based on the New York Heart Association (NYHA), functional class I/II, show increased expression of HIF-1α (236), whereas patients in end-stage HF (III/IV NYHA class), show decreased HIF-1α and PHD1 (241). This evidence concerns the gene HIF1A and hydrops fetalis.